Search - tctmd.com

Displaying 1 - 20 of 213

Sort: Relevancy | Date

News Daily News

CMS Finalizes Plans to Bundle Cardiac Care Payments

Caitlin E. Cox

December 21, 2016

News Daily News

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Michael O'Riordan

December 13, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Salvatore Cassese

October 30, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Laura Mauri

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

Presentation TCT 2016

Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR

Presenter: Colm Hanratty, Simon J. Walsh, James C. Spratt

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Michael O'Riordan

October 28, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

News Daily News

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

Todd Neale

October 28, 2016

News Daily News

Study Explores Possible Mechanism to Explain Air Pollution-CVD Link

Todd Neale

October 27, 2016

Advertisement

CMS Finalizes Plans to Bundle Cardiac Care Payments

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

Study Explores Possible Mechanism to Explain Air Pollution-CVD Link

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content